Statin Intolerance

Rev Cardiovasc Med. 2018;19(S1):S9-S19. doi: 10.3909/ricm19S1S0005.

Abstract

Statins are critical medications to prevent and treat cardiovascular disease2 and they are generally very well tolerated. In some instances, however, statin intolerance may limit use of these lifesaving medications. Statin intolerance has many definitions but is commonly diagnosed when a patient is unable to continue statin therapy due to perceived, or objectively documented, adverse effects. A very high rate of discontinuation of statin therapy warrants a closer look at the implications from the standpoint of cardiovascular risk in statin-intolerant patients, as well as an evaluation of the available options to help patients maintain their statin therapy and understand the potential benefits of such therapy.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Chemical and Drug Induced Liver Injury / epidemiology
  • Cholesterol, LDL / blood*
  • Cognition Disorders / chemically induced
  • Cognition Disorders / epidemiology
  • Diabetes Mellitus / chemically induced
  • Diabetes Mellitus / epidemiology
  • Drug Interactions
  • Drug Substitution
  • Dyslipidemias / blood
  • Dyslipidemias / diagnosis
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / epidemiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Muscular Diseases / chemically induced
  • Muscular Diseases / epidemiology
  • Risk Assessment
  • Risk Factors

Substances

  • Biomarkers
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors